VANI
Vivani Medical, Inc.Company with tickers: VANI
CIK
1266806
CUSIP
92854B109
Shares Outstanding
86,235,104
Website
https://www.vivani.com
Investor Relations
https://investors.vivani.com/investors
13F Activity (30d)
3 filings
2 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $6,817,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $4,390,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-6,817,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-6,780,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |